Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. Attorney Declines To Intervene In Caremark Qui Tam Suit

This article was originally published in The Pink Sheet Daily

Executive Summary

Illinois U.S. Attorney Patrick Fitzgerald joins colleagues from Florida and California in declining to intervene in qui tam suits against Caremark.

You may also be interested in...

States, U.S. Government Join Caremark "Whistleblower" Lawsuit Over Medicaid Claims

The qui tam suit alleges Caremark allowed Medicaid to pay for drugs for patients dually insured by Caremark's health plans and Medicaid, the Texas Attorney General's office says. Four states and the federal government have intervened. Caremark says the lawsuit seeks to impose payment obligations not required by law.

NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination

Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue

FDA’s Arcoxia Decision Offers New Evidence Of Conservative Review Stance

FDA's "not approvable" action on Merck's Vioxx follow-on Arcoxia for the treatment of symptoms of osteoarthritis could be indicative of a conservative regulatory climate at the agency





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts